Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123369092 | 12336909 | 2 | F | 20151013 | 20160923 | 20160505 | 20160927 | EXP | US-BAYER-2015-444107 | BAYER | 60.00 | YR | A | F | Y | 0.00000 | 20160927 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
123369092 | 12336909 | 1 | PS | NEXAVAR | SORAFENIB | 1 | Oral | 200 MG, BID | 21923 | 200 | MG | FILM-COATED TABLET | BID | ||||||
123369092 | 12336909 | 2 | SS | NEXAVAR | SORAFENIB | 1 | Oral | 600 MG DAILY DOSE(2TABLETS OF 200 MG QAM AND 200 MG QPM) | 21923 | FILM-COATED TABLET | |||||||||
123369092 | 12336909 | 3 | SS | NEXAVAR | SORAFENIB | 1 | Oral | 400 MG, BID | 21923 | 400 | MG | FILM-COATED TABLET | BID | ||||||
123369092 | 12336909 | 4 | SS | NEXAVAR | SORAFENIB | 1 | Oral | 400 MG, BID | 21923 | 400 | MG | FILM-COATED TABLET | BID |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
123369092 | 12336909 | 1 | Hepatocellular carcinoma |
123369092 | 12336909 | 2 | Hepatocellular carcinoma |
123369092 | 12336909 | 3 | Hepatocellular carcinoma |
123369092 | 12336909 | 4 | Hepatocellular carcinoma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
123369092 | 12336909 | HO |
123369092 | 12336909 | OT |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
123369092 | 12336909 | Arthralgia | |
123369092 | 12336909 | Haematochezia | |
123369092 | 12336909 | Hepatic cancer | |
123369092 | 12336909 | Medical procedure | |
123369092 | 12336909 | Pain in extremity | |
123369092 | 12336909 | Palmar-plantar erythrodysaesthesia syndrome | |
123369092 | 12336909 | Paraesthesia | |
123369092 | 12336909 | Procedural pain | |
123369092 | 12336909 | Pruritus | |
123369092 | 12336909 | Rash pruritic | |
123369092 | 12336909 | Skin exfoliation | |
123369092 | 12336909 | Urinary tract infection |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
123369092 | 12336909 | 1 | 20151001 | 0 | ||
123369092 | 12336909 | 2 | 2015 | 0 | ||
123369092 | 12336909 | 3 | 2015 | 20160319 | 0 | |
123369092 | 12336909 | 4 | 2016 | 0 |